https://www.selleckchem.com/pr....oducts/cyclo-rgdyk.h
In conclusion, RIC is a reasonable option for elderly patients with negative-MRD at HCT.Acute graft-versus-host disease (aGVHD) is a serious complication after stem cell transplantation and is associated with high non-relapse mortality. If steroid treatment as first-line therapeutic approach fails, treatment options are limited. In retrospective studies, ruxolitinib, a selective Janus kinase 1/2 inhibitor as well as extracorporeal photopheresis (ECP) could show high efficacy in treatment of steroid refractory acute and chronic GVHD.
Like
Comment
Share
